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CHAPTER 1




Individuals working within the health sector very often see their work as 
guided by collectively shared normative values. In particular there is an 
overarching goal of improving people’s health. Indeed the field of public 
health has been defined as “the science and art of preventing disease, pro-
longing life and promoting health through organized efforts of society” 
(Acheson 1988, p. 1). This is often linked, either implicitly or explicitly, 
to a concern for improving health equity (or reducing health inequali-
ties) – for instance within the World Health Organization’s calls to achieve 
‘health for all’ (Detels and Tan 2015; Whitehead 1991). In recent decades, 
efforts to improve population health and to reduce health inequalities 
within countries and globally between states, have been linked with calls 
for evidence based policy (EBP). Drawing on the idea of evidence based 
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medicine (EBM), health policy actors see engagement with policy-relevant 
evidence to identify more effective, and by extension cost effective, inter-
ventions as the way to achieve their overarching policy objectives.
EBM as a concept is based on the idea that medicine should be prac-
ticed by making “conscientious, explicit, and judicious use of current best 
evidence in making decisions about the care of individual patients” (Sackett 
et al. 1996, p. 71). The origin of this idea is often attributed to Archie 
Cochrane, who wrote in the early 1970s about the need to use evidence of 
effectiveness to guide clinical practice (Cochrane 1972), although it was in 
1993 that the formal establishment of the Cochrane Collaboration further 
served to provide both a global repository of evidence for specific clinical 
interventions, and an authority for best practices on how to review or 
select evidence to inform medical practice (Starr et al. 2009).
The notion of ‘conscientious, explicit, and judicious’ evidence use is 
relevant to consider in this context. From the earliest origins of the EBM 
movement, there was recognition that it is not necessarily appropriate to 
rely solely on research evidence when making decisions on diagnoses and 
medical treatment. Professional experience and judgement on the part of 
medical practitioners, in light of the evidence base and relevant inferences 
from this, remain important (Sackett et al. 1996). However, over time, the 
principles of EBM have gravitated towards specific types of evidence with 
clear preferences for certain study designs  – encapsulated in so-called 
‘hierarchies of evidence’ (Petticrew and Roberts 2003) – reflecting con-
cerns about the internal validity of studies and the potential for biased 
outcomes that, in medicine, “routinely lead to false positive conclusions 
about efficacy” (Sackett et al. 1996, p. 72).
The EBM movement has, overall, been heralded as a triumph and is 
credited with ensuring that medical treatments produce beneficial results, 
particularly compared to the past, when many interventions were pro-
moted solely on the basis of hypotheses of potential cause and effect that 
may, in fact, have been incorrect (Howick 2011). The Academy of Medical 
Royal Colleges, for instance, has argued that EBM “is the key to the suc-
cess of modern Healthcare” (Sense About Science and Academy of Royal 
Medical Colleges 2013, p. 1), co-authoring a report providing examples of 
how EBM has improved health outcomes on a range of issues from HIV/
AIDS treatment to emergency allergy care and mental health treatment 
(Sense About Science and Academy of Royal Medical Colleges 2013).
The success of EBM has been seen by many authors as the inspiration 
for calls to expand the concept to other forms of decision making  including 
‘evidence based policymaking’ in health and other social policy areas 
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(Berridge and Stanton 1999; Wright et al. 2007; Lin and Gibson 2003; 
Parkhurst 2017). This is despite recognition of the challenges in appropri-
ating ideas from clinical practice and applying them to shape policymaking 
processes. For example, Black (2001) urged the medical community to 
‘proceed with care’ with the idea of evidence based policy due to the quali-
tatively different nature of policymaking compared to medicine. A num-
ber of other authors have similarly argued that the political realities of 
policy decisions mean policy cannot simply be ‘based’ on evidence in the 
same way as clinical decisions and that the notion of a linear-rational rela-
tionship between evidence and policy is a fallacy (c.f. Lewis 2003; 
Hammersley 2005; Greenhalgh and Russell 2009).
Russell et al. (2008), for example, have explained that:
…academic debate on health care policy-making continues to be couched in 
the dominant discourse of evidence-based medicine, whose underlying 
assumptions – that policies are driven by facts rather than values and these 
can be clearly separated; that ‘evidence’ is context-free, can be objectively 
weighed up and placed unproblematically in a ‘hierarchy’; and that policy- 
making is essentially an exercise in decision science. (p. 40)
These messages appear to have had only limited impact on the concep-
tual vocabulary of health policy making and scholarship. Despite these 
warnings, the language of ‘evidence based policymaking’ has become 
firmly established in health policy discourses, particularly in the United 
Kingdom (UK), Canada, and within many global health networks. As 
such, recent publications have continued to critique examples of the over-
simplified or idealised embrace of evidence on which to ‘base’ policy (c.f. 
Hammersley 2013; Cartwright and Hardie 2012; Parkhurst 2017). In 
addition, recent systematic reviews have found limited engagement with 
the political nature of policymaking to help explain evidence use. Oliver, 
Innvaer, and Lorenc (2014a) concluded from one such review that while 
studies of evidence use have spread from health to other sectors, few works 
actually engage with aspects of the policy process or provide sufficient 
details to draw firm conclusions. In a related paper, the authors argue that:
The agenda of ‘getting evidence into policy’ has side-lined the empirical 
description and analysis of how research and policy actually interact in vivo. 
Rather than asking how research evidence can be made more influential, 
academics should aim to understand what influences and constitutes policy, 
and produce more critically and theoretically informed studies of decision- 
making. (Oliver et al. 2014b, p. 1)
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Another review by Liverani et  al. (2013) (undertaken as part of the 
research programme making up this volume), similarly reviewed literature 
on evidence use related to health policymaking and found few examples 
that explicitly addressed politics to help explain the use of evidence to 
inform health policymaking.
Given this state of affairs, this book aims to contribute to a greater 
understanding of the political nature of policymaking and how it shapes 
the potential for, and resultant outcomes of, evidence use in health policy-
making. In particular, we focus on scientific evidence arising from research 
and related systematic processes of data collection (e.g. data collection for 
monitoring the health system) as our principle subject. This is because, 
while we recognise that the term ‘evidence’ can take many meanings – 
including personal experience and legal argumentation – it is the formal 
results of research activity and the application of the scientific method that 
have been seen as essential to the aspirations of both the EBM and the 
EBP movements.
We argue that while policy advocates have pursued their normative 
goals of improving health outcomes through ‘better’ policymaking, asso-
ciated with reliance on research evidence, this has brought about a dis-
course that too narrowly focuses on certain conceptions of what counts as 
policy-relevant evidence. In addition, it overstates the role which evidence 
is able to play in the policy making process whilst paying insufficient atten-
tion to the politics of that process, including the competition of values, 
ideologies, and policy objectives which cannot themselves be determined 
by recourse to evidence.
There is thus a need to examine the complex interrelationship of evi-
dence use and politics to form a more nuanced conception of the health 
policy process. This starts from an explicit recognition of the fundamen-
tally political nature of the policy process that recognises that, while evi-
dence can and should be an important factor informing policy debates, it 
cannot provide the sole basis for policy decisions or is usually insufficiently 
suited to resolve policy conflicts.
The Multiple Meanings of ‘Use’ of Research Evidence
The point of departure for developing our conceptualisation of how evi-
dence informs policy is to start by questioning what it means to ‘use’ evi-
dence in policymaking. Unlike clinical decision making, which often 
involves a choice between clearly circumscribed interventions for a fairly 
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specific purpose (to improve patient outcomes), using evidence to inform 
policy usually does not fit this model. More often than not, policy is not a 
clearly delineated object, and there may be disagreement not just about 
the preferred policy ‘solution’, but also about the nature and definition of 
the problem to be addressed.
That evidence use in policymaking is not entirely compatible with 
notions of instrumental rationality has been known for some time. Indeed, 
Carol Weiss (1979) described a number of different meanings of research 
utilisation in the late 1970s. She discusses social science research more 
widely, but her models of research use are conducive to health policy 
research as well. In particular, she identifies seven variants of research utili-
sation, including a ‘knowledge-driven’ model in which basic research 
identifies new social problems; a ‘political’ model in which research is stra-
tegically used to achieve pre-existing goals; and an ‘enlightenment’ model 
in which research influences broader thinking more generally.
The model that perhaps best aligns with the current dominant rhetoric 
in the health sector, however, is Weiss’ so-called ‘problem solving’ model 
of research utilisation, which sees direct application of a study’s findings 
(for example findings from an evaluation of an intervention) to inform a 
specific policy decision (for example, a decision about which intervention 
to fund). Weiss, however, notes that it requires a tremendous, and incred-
ibly rare, alignment of circumstances to see research used in this way. 
Indeed, this requires the identification, and agreement on the definition of 
a problem that policy and research are expected to address. In practice, of 
course, both problems and their solutions tend to be highly contested. For 
example, to some, health inequalities run counter to accepted norms of 
social justice and are thus identified as legitimate targets of government 
intervention, while for others inequalities are seen as the outcome of per-
sonal choices and thus beyond the remit of the state. Similarly, for some, 
governments are seen to have a responsibility to care for all, while for oth-
ers government intervention in health is seen as an unwelcome overreach 
or intrusion on individual and market freedoms.
Contestation between groups who have different sets of values or 
beliefs in many ways is at the heart of many theories of policy change 
which perceive policymaking as a competitive process rather than a tech-
nocratic one (Sabatier 2007; John 1998). Yet it has been argued that the 
level and nature of these competitive environments can incentivise the 
manipulation of scientific or empirical evidence to achieve desired political 
goals (Parkhurst 2016). As a result, strategic, rather than instrumental 
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uses of evidence appear commonplace in many policy arenas where politi-
cal interests exist – often decried as ‘policy-based evidence-making’ and 
seen as a fundamental challenge to the ideal rational use of evidence that 
many social sector stakeholders champion (Marmot 2004; Strassheim and 
Kettunen 2014).
Nutley et al. (2007) have also provided a comprehensive mapping of 
many potential meanings of evidence use/utilisation that includes, but 
expands on Weiss’ original concepts. They identify that “the most com-
mon image of research use is of an instrumental process that involves the 
direct application of research to policy and practice decisions” (p.  34). 
However, the authors detail a number of other ways to conceptualise 
research use beyond this simple view. This includes producing typologies 
of evidence use (similar to Weiss’ (1979) model), as well as models which 
see practices of evidence use as a continuum from more conceptual to 
more instrumental uses, or instead considering evidence use as a process 
or series of stages rather than as one or more types.
These works highlight the limitations of instrumental approaches to 
evidence use, even if this continues to be held up as an ideal in many aca-
demic and professional circles. Yet mapping the different ways research 
and evidence are used does not, on its own, explains neither why we see 
different forms of evidence use arise at different times and in different 
contexts, nor what constitutes a ‘good use of evidence’ in particular policy 
areas. This is particularly important when reflecting on the specific goals of 
health sector actors, and the common belief across that sector about how 
robust use of evidence (and in particular of research evidence) will help to 
achieve those goals. In this volume we thus attempt to move forward from 
these initial mapping exercises to directly engage with the political nature 
of policymaking to reflect on how evidence is used within the health sec-
tor. This approach allows explicit consideration of the systems in place that 
work to provide evidence to policy decision makers, or seek to improve 
evidence use in some way.
A PublIc PolIcy PersPectIve
A public policy perspective on evidence use accepts that political dimen-
sions of health policymaking will affect the relevance and use of evi-
dence within those policy processes. Yet the policy sciences are a broad 
field, consisting of a wide range of theories and concepts that can each 
be used to provide insights into policy processes and outcomes. Thus 
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calling for more public policy insights requires consideration of how 
precisely to apply this field of work to study evidence use in a compara-
tive perspective.
Previous authors have engaged with theories of policy change to help 
explain when or how evidence might be used within policy processes. Yet 
what is apparent from these works is that there is a tremendous range of 
theories that could provide insights in one or another way to this question. 
Cairney (2016) highlights the relevance of a number of theories, frame-
works, and approaches including: multiple streams theory, punctuated 
equilibrium theory, social constructionism, narrative frameworks, the 
advocacy coalitions framework, studies of policy transfer or diffusion, and 
complexity theory (see Cairney 2016, chapter 2). Cairney, however, 
embraces the usefulness of the concept of bounded rationality in particu-
lar, due to his work having a central focus on policy makers’ perspectives 
and a need to overcome the comprehensive rationality underlying the 
evidence-based policymaking thinking. Smith (2013a) reviews many of 
the same theories as Cairney, including theories of policy change, but 
focuses on the ‘power of ideas’ to shape what is considered relevant evi-
dence, and to affect the roles and actions of policy actors for two contrast-
ing health policy issues: health inequalities and tobacco control.
The variety of policy studies theories thus provides a range of explana-
tory perspectives to consider different questions about policymaking and 
policy change. For example, if one was concerned with how evidence fits 
within ongoing processes of policy change, Kingdon’s multiple streams 
approach or the Advocacy Coalitions Framework could be the most appro-
priate approaches to adopt. We are sympathetic to this wide variety of 
approaches and the insights they can provide into particular questions of 
evidence use.
However, in this volume we focus on two particular approaches derived 
from the policy sciences. First, we engage with the contested nature of 
policy decisions between multiple stakeholders who may be pursuing dif-
ferent interests, and conceptualising policy problems in different ways. 
Second we consider the influence of the political institutions that work to 
shape when and how particular forms of evidence influence policy deci-
sions in different settings. Our decision to focus on these factors arose 
primarily from a desire to explore how the political nature of the policy 
process affects evidence use in different settings; as well as a desire to 
understand which forms of evidence use arise in different institutional 
contexts.
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Politics as Power and Contestation
One of the most widespread criticisms of calls for ‘evidence based policy-
making’ comes from authors who point to the inherently contested nature 
of policy decisions. Unlike in clinical decision situations, policy is, as 
Lasswell (1990 [1936]) classically observed, about ‘who gets what, when 
and how’, emphasising the possibility of conflict over the distributive 
effects of policy. Ultimately, policy-making is about power and influence, 
and the ability of policy actors to generate or withhold support and influ-
ence an outcome. It is therefore not possible to separate policymaking 
from politics. Scholars have historically noted that policymaking repre-
sents decisions, made on behalf of society, to decide on what collective 
goals that society should pursue (Brecht 1959). As such it can be argued 
that these processes require some form of democratic legitimation that 
would typically be derived from ensuring that multiple interests are articu-
lated or considered in the decision making process (even if some are 
excluded in the final choice of outcome) (Young 2000). In such a process, 
however, competing stakeholders participating in this process will seek to 
frame the terms of policy debates in way amenable to the objectives in 
order to shape decisions (Russell et al. 2008), with the recourse to ‘evi-
dence’ serving as one mechanism through which policy discourses can be 
shaped in favour of (or against) a particular outcome.
In many instances there are wide asymmetries of power between differ-
ent actors with obvious consequences for their ability to influence the defi-
nition of the policy problem, for example through issue framing, and the 
type of intervention put in place to address them (Lukes 2005). Trans- 
national corporations, for example the global tobacco and alcohol indus-
tries, have enjoyed high degrees of success in shaping policy and the wider 
debates which surround policy decisions, not simply through direct lobby-
ing, but through their use of media consultants, public relations and cor-
porate social responsibility campaigns (Hawkins and Holden 2013).
The importance of issue framing in policy debates is thus critical to 
understand, both in relation to the construction of policy-relevant concep-
tualisations of evidence and in relation to what can be achieved by appeals 
to evidence in the context of highly contested policy debates. The framing 
of an issue can shape the way in which a policy problem is seen; the very 
essence of what it ‘is’ for the observer. This affects what the correct and 
legitimate policy response to this is considered to be, and thus what is 
identified as the most relevant body of evidence in assessing the policy 
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problem under consideration and the proposed responses (c.f. Bacchi 
2009; Fischer 2003). If we accept multiple, often mutually exclusive, fram-
ings of policy problems are possible, each claiming support from different 
(sometime overlapping) bodies of evidence, then the impossibility of set-
tling policy dilemmas through recourse to the evidence becomes acutely 
apparent. This is why Russell et al. (2008) noted that it is ‘naively rational’ 
to assume that evidence can simply direct policy making in a linear way, 
with Hammersley (2013) going so far as to claim that ‘evidence- based 
policy’ is nothing more than a slogan used to discredit opponents.
Recognising the contested nature of decision making means that the 
specific form of issue contestation, the strength of relevant interests, the 
power of stakeholders and their networks, and their ability to frame prob-
lems and solutions, can be expected to play important roles in shaping 
how evidence is used within health policymaking processes. From this per-
spective, the actors involved in policymaking take centre stage analytically, 
with regard to the interest they may represent, the strategies they pursue 
and the behaviours they display to achieve their desired outcome. Focusing 
on contestation therefore allows for a deeper analysis of the role of actors, 
their interests, and agency. It also allows an alternative conceptualization 
of evidence use in policy processes. As Weiss (1979, 1991) already 
observed, actors can use evidence strategically or tactically to support a 
decision and to delegitimise other positions that are not supported by 
evidence (or by evidence of the same methodological robustness). 
Likewise, it is conceivable that evidence is used to build support and gen-
erate ‘buy-in’ and consensus, especially from audiences that are likely to 
support the notion that evidence should be a key ingredient of policy-
making. In practice such efforts can fail as well as succeed. It will therefore 
be difficult to clearly separate different uses of evidence, which may be 
simultaneously instrumental and strategic.
Lines of contestation can be studied through a variety of case study 
types, including analysis of a single health issue in a single context; of 
 multiple health issues in a single context; or for the same health issue in 
different contexts. We have examples of all of these within this volume. 
However, policy contestation is merely a starting point to apply the policy 
sciences to the study of evidence use, even with the depth of conceptual 
insights this initial step allows. Our driving interest was not only to look at 
single decision events or policy choices, but to consider longer term and 
systemic uses of evidence within the health sector. This means recognition 
that evidence use in decision making is not just a single occurrence or 
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event, but rather it is an ongoing process integral to the policy process. 
Thus the second main component to our conceptual approach is to engage 
with concepts of institutionalism in order to explore how institutions 
shape and direct the ongoing use of evidence affecting health decisions 
across multiple decision points and over longer time frames.
An Institutional Perspective to Analyse 
Evidence Use in Policy Processes
Lowndes and Roberts (2013) posit that “[i]nstitutions are central to the 
subject matter of political analysis (p. 1),” and, indeed, institutional anal-
ysis is well established in the fields of political analysis and international 
public policy comparisons, including comparisons of health systems and 
reforms (Immergut 1992; Tuohy 1999). Given its history with EBM, 
many look to the health sector in particular as leading other social sectors 
in its engagement with evidence use (Parkhurst 2017); but even in this 
field, only a small number of studies to date have directly analysed institu-
tions in relation to evidence use for policy. Some of these have focussed 
on organisational arrangements that facilitate or hinder the uptake of 
pieces of evidence; for example in relation to drug policy in England and 
Scotland (Nutley et  al. 2002), in health inequality policy in England 
(Smith 2013b), or, in relation to clinical practice, in routine nursing prac-
tice in US hospitals (Stetler et al. 2009). The interest in organisational 
arrangements is also reflected in some current work on organisational 
‘embeddedness’ of evidence use as well within health policymaking bod-
ies (c.f. Gonzales- Block 2013; Koon et al. 2013). Other work has looked 
at institutionalised processes of evidence use to inform fairly circum-
scribed sub-fields of health policy, such as coverage decisions relating to 
publicly funded health services and pharmaceuticals, with the use of 
health technology assessment (HTA) a prominent example (Garrido 
2008; Turchetti et al. 2010).
However, our own systematic review of studies on evidence use, could 
find only a limited engagement with the concept of institutions, especially 
political institutions relevant to policymaking, to help explain the use of 
evidence in policymaking in the health-related literature (Liverani et al. 
2013). This echoes an earlier finding by Nutley et al. (2002), who looked 
at public policy more broadly and concluded that “insufficient attention 
has been paid to the institutional arrangements for connecting research 
(and other evidence) to policy (p. 77).”
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Therefore, we find that a significant gap in the literature still exists to 
consider institutions more directly in relation to their role in shaping evi-
dence use for health policy making. In this volume, we draw on the 
broader concepts typical of new institutionalism, as explored by authors 
such as Peters (2005, 2008) and Lowndes and Roberts (2013), who see 
new institutionalism as a way to move beyond historical work that focussed 
solely on formal arrangements of political systems, to additionally consider 
how institutional rules, practices, and narratives work to shape policy actor 
behaviour.
From this perspective, and based on the analyses in the chapters that fol-
low, we stipulate that institutional structures, norms, practices, and narratives 
will influence evidence use in policymaking in two ways. First, institutional 
arrangements will shape the processes of policymaking and thus determine 
which actors have access to policy and whose positions are considered rele-
vant or legitimate. This can be formal, for example through stipulations as 
to who will be involved any given policy decision, or informal, with actors 
having an implicit understanding, or a shared perception, of the appropri-
ateness of who should be involved in and who excluded from the decision 
process. This focus on the roles of key policy actors helps to capture the 
institutionalised features of policy contestation in different settings, akin to 
what Peters (2005) describes as a rational choice branch of new institutional-
ism which maintains a focus on policy actors pursuing their interests within 
institutional arrangements. We have used this perspective in a number of 
different countries to analyse how different institutional arrangements 
influence which stakeholders bring evidence of different kinds to policy 
processes, often in the pursuit of particular interests.
Second, efforts to improve the use of evidence in policymaking can 
themselves lead to the creation of new structures, rules, practices, and nar-
ratives that inform future policy decisions, i.e. evidence utilisation of one 
form or another can become institutionalised, described elsewhere as 
‘governing’ how evidence is used (c.f. Hawkins and Parkhurst 2015; 
Parkhurst 2017). For example, governmental or non-governmental bod-
ies have been set up in countries with the explicit aim of generating, assess-
ing or synthesising evidence to develop a more consistent (and often a 
more instrumental) approach to evidence use in policy. In order to exer-
cise their mandate, these bodies have, over time, created a set of rules and 
practices that guide how they execute their mandates and go about their 
tasks. These rules and practices are typically accompanied by ideas about 
the ‘right’ types of evidence (e.g. the ‘hierarchy of evidence’), methods of 
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appraisal and synthesis, and ways of using them in decision-making (c.f. 
Sutherland 2001; Petrisor and Bhandari 2007; Evans 2003; Borgerson 
2009). Bodies such as these also operate with a legal framework set by 
government or legislatures, which can lead to instances where their deci-
sions may be challenged or overridden by other political institutional 
structures (c.f. Chap. 5 in this volume and Ettelt forthcoming).
Critically exploring these concepts can utilise what Peters (2005) 
describes as normative institutionalism, which applies ideas such as March 
and Olsen’s (1989, 2006) ‘logics of appropriateness’. This concept is in 
many ways the antithesis of rational choice perspectives that see individuals 
as pursuing their own interests, and instead explores how, within institu-
tional arrangements, individuals work towards outcomes guided by collec-
tive normative principles of what is seen to be the correct thing to do, or 
what is the right outcome to achieve. This can therefore be used to explore 
how practices play out within key administrative bodies in relation to domi-
nant ideas about evidence use (or about evidence-based policymaking) 
within the health sector; and further allows consideration of how alterna-
tive logics play out when health related policymaking takes place across 
institutions and policy sectors with their own distinct normative goals.
Institutions can be formal and informal, as well as explicit and implicit, 
which means that at times they can be difficult to pin down analytically or 
observe empirically. Yet all permutations may play out in important ways to 
shape evidence use in different political contexts. Rules such as legislation 
would be at the formal, explicit end of the spectrum, while narratives and 
discourses about which behaviours of policy actors are appropriate are 
more likely to be informal (and potentially implicit). In combination, insti-
tutional elements form structures and logics that shape how actors behave, 
how they relate to each other, and how they relate to policy processes, both 
individually and collectively. Ultimately these factors can play important 
roles in shaping which of the many forms of evidence use arise in different 
health policy processes – be it instrumental uses in line with idealised views 
of the health community, strategic uses by policy actors to pursue their 
interests, or some other form or combination of the types of evidence use.
outlIne of the book
The remainder of this book presents a set of chapters consisting of country 
case studies and comparative analyses that arose from a five-year research 
project supported by the European Research Council entitled ‘Getting 
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Research into Policy in Health’ (the GRIP-Health project). The project 
aimed to improve the understanding and practices of evidence use by 
examining health policy processes in six countries cutting across low, mid-
dle, and high income settings, as well as varying in their geographic loca-
tion and administrative arrangements. Specifically cases come from 
Cambodia, Colombia, Ethiopia, Germany, Ghana, and the United 
Kingdom (analysed as the UK in Chap. 7, but more narrowly focussing on 
England in other comparative chapters).
The first set of chapters presents findings from individual country- 
focussed investigations. These examined one or more health policy topics, 
as well as processes of decision making, with explicit consideration of the 
contestation of the issues and/or the institutional arrangements in place 
that end up affecting the use of evidence.
Chapter 2 presents the first of our country examples with a case study 
from Cambodia that specifically looks at the differences in evidence use for 
three contrasting health policy issues – HIV/AIDS, tobacco control, and 
performance based financing of midwifery services. The chapter illustrates 
that despite the broad rhetorical embrace of the concept of evidence based 
policymaking within the health sector, the extent to which evidence is 
used in instrumental ways can vary substantially depending on the political 
realities of specific policy topics, including competing governmental inter-
ests in issues or the conceptual framing about what evidence is meant to 
achieve in different cases. The chapter considers the differing logics of 
actors in each policy process and how these shape evidence use for differ-
ent health issues.
Chapter 3 follows with an analysis from Ethiopia that looks specifically 
at the challenges to multisectoral planning for nutrition in that country. It 
continues the concern over logics of appropriateness in relation to  evidence 
use by reflecting on how different sectors (health, agriculture, finance, 
etc.) may see their goals and thus their perceptions of policy relevant evi-
dence in different ways. The chapter also reflects on the constructed nature 
of the framing of nutrition policy in the country, which could reflect com-
peting goals between differing policy sectors. Overall it considers how 
these features make multisectoral planning, and the use of evidence within 
such planning, a challenge.
Chapter 4 presents a case from Ghana that, rather than looking at a 
specific policy topic, focusses on a key part of the evidence advisory system 
of the country. Specifically, the Chapter investigates the institutional sys-
tem in place which dictates how routine local data is used to inform annual 
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health sector planning and policy reviews. The chapter considers how the 
data and evidence review process has been institutionalised in ways that 
not only shape which data and pieces of evidence inform certain planning 
activities, but which also may have governance implications in terms of the 
systems of accountability in the country, and the role or influence of inter-
national funding agencies.
In Chap. 5, a case study in Colombia further expands the institutional 
lens to look more broadly at the role of the legislature within ongoing 
health systems reform debates. The chapter also engages directly with the 
importance of policy contestation in shaping when evidence will, or will 
not, have a role in influencing legislative outcomes. The analysis illustrates 
that even though scientific evidence was found to be available to decision 
makers, it was unable to provide common ground or positions of compro-
mise within the highly contested and fragmented health policy field.
Chapter 6 presents a case study from Germany that particularly explores 
the instrumental and strategic uses of evidence to inform debates about 
minimum service volumes in hospitals (i.e. whether facilities should have 
to provide a minimum number of procedures to be allowed to offer the 
service). The analysis illustrates how the interests of key actors can lead to 
strategic uses of evidence, but further highlights the dynamic relationship 
between evidence use and the political and institutional context, exploring 
how the legislative nature of policy-making, corporatism, and the role of 
the judiciary in Germany influence these uses of evidence in this case.
The final country case study in this section comes in Chap. 7 presenting 
the case of electronic cigarette policy in the UK. This case study focuses on 
the contested nature of policy debates, but further considers the importance 
of how alternative constructions or framings of the policy issue itself by com-
peting groups may help to explain how evidence is used. The chapter then 
discusses why appeals to particular forms of evidence do not have the impact 
that many health actors might expect. It concludes by reiterating a core 
theme of this volume that the political nature of policy debates must be 
engaged with explicitly to understand evidence use for health policymaking.
Following these country specific chapters, we present a set of three 
comparative analyses that draw lessons from across multiple country cases 
to address key themes arising from the project. Chapter 8 begins with a 
direct consideration of the institutional systems in place that work to pro-
vide evidence to inform decision making by Ministries of Health. It begins 
by considering the roles that Ministries of Health have as stewards of 
national health care, considering how this can also extend to having a 
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mandate to shape the evidence advisory systems which will inform health 
policy decisions. It then looks across all six of our country cases to con-
sider whether such systems provide relevant information in a timely man-
ner to key decision points. The chapter illustrates how key structural and 
practical differences exist between countries, and also notes that, at times, 
key health decisions lie outside the authority of Ministries of Health, pro-
viding further challenges to the roles that formalised evidence advisory 
systems might play to inform those decisions.
This recognition of non-ministerial authority over health decisions 
leads directly to Chap. 9, which discusses insights about the roles of 
legislatures and the judiciary in shaping evidence use for health deci-
sions. The chapter draws out lessons from multiple country case studies 
to illustrate the different ways that these bodies may use evidence to 
classic ideas of instrumental or problem-solving use embraced by many 
health sector actors. Ultimately the chapter draws out just how different 
evidence use can look within national policy processes based on existing 
institutional systems embedded in the legal or constitutional frame-
works of countries.
Chapter 10 presents the final comparative chapter, drawing lessons on 
evidence use in relation to the role and potential influence of international 
aid donors in our lower-income, aid-dependent case study countries 
(Ethiopia, Cambodia, and Ghana). The chapter draws out the importance 
of factors such as: the levels of local technical capacity, differing stake-
holder framings of issues, and the influence of external actors on underly-
ing systems of decision making. The chapter discusses how these were seen 
to affect which evidence was used and for what purposes – illustrating how 
the broader political economy of aid and development can play out in 
multiple ways in terms of evidence use in health policymaking.
Finally, Chap. 11 provides a discussion chapter that allows us to reflect 
on the issues raised in this introduction. We revisit what our cases show in 
terms of the many meanings of research utilisation, and consider what has 
been learned in terms of how political and institutional factors shape the 
form of evidence use arising in health policy processes. The chapter syn-
thesises insights about how political contestation, issue construction, and 
institutional arrangements all work (and at times work together) to shape 
and direct evidence use. The chapter, however, concludes by recognising 
that the insights from this volume only present a starting point to under-
standing the politics of evidence use from a public policy perspective, 
merely scratching the surface of the many areas of research that can further 
be done in this field.
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